Hunan Zhenghong Science and Technology Develop Co.,Ltd. carries a market capitalization of 1.79B, placing it among publicly traded companies globally. Its enterprise value stands at 2.49B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.79B |
| Enterprise Value | 2.49B |
Hunan Zhenghong Science and Technology Develop Co.,Ltd. currently has 346.62M shares outstanding.
| Shares Outstanding | 346.62M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 2.12, and the price-to-book ratio stands at -18.51.
| PE Ratio | N/A |
| PS Ratio | 2.12 |
| PB Ratio | -18.51 |
| P/TBV Ratio | 8.63 |
| P/FCF Ratio | 182.34 |
| P/OCF Ratio | N/A |
| EV / Sales | 2.11 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 98.06 |
Hunan Zhenghong Science and Technology Develop Co.,Ltd. maintains a current ratio of 1.07, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 44.82, indicating elevated leverage, while an interest coverage ratio of -1.02 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.07 |
| Quick Ratio | 0.36 |
| Debt / Equity | 44.82 |
| Debt / EBITDA | -11.20 |
| Interest Coverage | -1.02 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -9.71 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -154.83 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 12.18 |
| Income Tax | -89,386.98 |
| Effective Tax Rate | N/A |
Hunan Zhenghong Science and Technology Develop Co.,Ltd.'s stock has declined approximately -30.27027% over the past 52 weeks. The 50-day moving average sits at 6.13, while the 200-day moving average is 6.74.
| Beta (5Y) | N/A |
| 52-Week Price Change | -30.27027% |
| 50-Day Moving Average | 6.13 |
| 200-Day Moving Average | 6.74 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Hunan Zhenghong Science and Technology Develop Co.,Ltd. generated 1.18B in revenue and converted that into -62.02M in net income, yielding earnings per share of -0.08. EBITDA reached -11.85M, while operating income came in at -11.85M.
| Revenue | 1.18B |
| Gross Profit | 67.13M |
| Operating Income | -11.85M |
| Pretax Income | -29.31M |
| Net Income | -62.02M |
| EBITDA | -11.85M |
| EBIT | -11.85M |
| Earnings Per Share (EPS) | -0.08 |
Hunan Zhenghong Science and Technology Develop Co.,Ltd. holds 91.77M in cash and equivalents against 132.79M in total debt, resulting in a net debt position of 33.35M. Total book value stands at -135.35M, with working capital of 17.01M providing operational flexibility.
| Cash & Cash Equivalents | 91.77M |
| Total Debt | 132.79M |
| Net Debt | 33.35M |
| Equity (Book Value) | -135.35M |
| Book Value Per Share | -0.39 |
| Working Capital | 17.01M |
After subtracting -13.74M in capital expenditures, free cash flow totaled -13.74M - equivalent to -0.04 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -13.74M |
| Free Cash Flow | -13.74M |
| FCF Per Share | -0.04 |
Hunan Zhenghong Science and Technology Develop Co.,Ltd. operates with a gross margin of 5.68, reflecting its pricing power and cost economics. The operating margin of -1.00 and net profit margin of -5.25 provide insight into operational efficiency.
| Gross Margin | 5.68 |
| Operating Margin | -1.00 |
| Pretax Margin | -2.48 |
| Profit Margin | -5.25 |
| EBITDA Margin | -1.00 |
The company's payout ratio of 329.84 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.03 |
| Dividend Yield | N/A |
| Payout Ratio | 329.84 |
| Shareholder Yield | 6.57 |
| FCF Yield | 0.55 |
Hunan Zhenghong Science and Technology Develop Co.,Ltd.'s most recent stock split took place on March 1, 2001 with a 5:9 split ratio.
| Last Split Date | 3/1/2001 |
| Split Ratio | 5:9 |
Hunan Zhenghong Science and Technology Develop Co.,Ltd. posts an Altman Z-Score of 6.51, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 6.51 |